Jonathan M. Mansbach, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bronchiolitis | 94 | 2024 | 485 | 14.380 |
Why?
|
Respiratory Syncytial Virus Infections | 33 | 2024 | 366 | 5.700 |
Why?
|
Bronchiolitis, Viral | 17 | 2024 | 82 | 4.230 |
Why?
|
Rhinovirus | 25 | 2023 | 203 | 3.550 |
Why?
|
Picornaviridae Infections | 15 | 2021 | 95 | 3.450 |
Why?
|
Respiratory Sounds | 16 | 2021 | 702 | 2.850 |
Why?
|
Respiratory Syncytial Virus, Human | 13 | 2023 | 150 | 2.840 |
Why?
|
Respiratory Syncytial Viruses | 11 | 2020 | 168 | 2.490 |
Why?
|
Nasopharynx | 21 | 2022 | 401 | 2.360 |
Why?
|
Respiratory Tract Infections | 9 | 2022 | 1010 | 2.070 |
Why?
|
Hospitalization | 42 | 2024 | 10723 | 1.540 |
Why?
|
Infant | 106 | 2024 | 36192 | 1.490 |
Why?
|
Asthma | 25 | 2023 | 6234 | 1.290 |
Why?
|
Nasal Cavity | 3 | 2018 | 304 | 0.990 |
Why?
|
Antimicrobial Cationic Peptides | 3 | 2017 | 353 | 0.960 |
Why?
|
Moraxella | 5 | 2019 | 25 | 0.960 |
Why?
|
Length of Stay | 17 | 2020 | 6425 | 0.900 |
Why?
|
Nasal Mucosa | 4 | 2019 | 416 | 0.870 |
Why?
|
Croup | 1 | 2022 | 23 | 0.820 |
Why?
|
Trachea | 2 | 2018 | 1089 | 0.790 |
Why?
|
Haemophilus | 4 | 2019 | 28 | 0.780 |
Why?
|
Common Cold | 5 | 2020 | 63 | 0.760 |
Why?
|
Coronavirus | 2 | 2020 | 154 | 0.740 |
Why?
|
RNA, Ribosomal, 16S | 5 | 2020 | 1039 | 0.740 |
Why?
|
Streptococcus | 3 | 2019 | 198 | 0.730 |
Why?
|
Metabolome | 13 | 2024 | 989 | 0.720 |
Why?
|
Apnea | 2 | 2019 | 195 | 0.690 |
Why?
|
Erythema | 1 | 2021 | 262 | 0.670 |
Why?
|
Child, Hospitalized | 1 | 2021 | 182 | 0.670 |
Why?
|
Bronchodilator Agents | 6 | 2018 | 512 | 0.660 |
Why?
|
Vitamin D Deficiency | 8 | 2018 | 1388 | 0.650 |
Why?
|
Staphylococcus | 3 | 2018 | 154 | 0.650 |
Why?
|
Prospective Studies | 64 | 2024 | 54425 | 0.640 |
Why?
|
Vitamin D | 12 | 2023 | 3303 | 0.630 |
Why?
|
Biofilms | 1 | 2022 | 628 | 0.590 |
Why?
|
Tracheostomy | 2 | 2018 | 426 | 0.580 |
Why?
|
Emergency Service, Hospital | 14 | 2024 | 7879 | 0.580 |
Why?
|
Influenza Vaccines | 1 | 2024 | 768 | 0.550 |
Why?
|
Influenza, Human | 2 | 2024 | 1521 | 0.530 |
Why?
|
Child, Preschool | 34 | 2024 | 42230 | 0.520 |
Why?
|
Serum Albumin | 1 | 2019 | 672 | 0.520 |
Why?
|
Severity of Illness Index | 24 | 2024 | 15842 | 0.510 |
Why?
|
Viruses | 4 | 2023 | 375 | 0.510 |
Why?
|
Infant, Premature, Diseases | 1 | 2021 | 710 | 0.510 |
Why?
|
Critical Care | 7 | 2019 | 2696 | 0.470 |
Why?
|
Aftercare | 1 | 2020 | 914 | 0.460 |
Why?
|
Nasopharyngitis | 1 | 2013 | 10 | 0.460 |
Why?
|
Pharynx | 2 | 2016 | 432 | 0.460 |
Why?
|
Proteobacteria | 1 | 2013 | 46 | 0.450 |
Why?
|
Depression, Postpartum | 1 | 2018 | 346 | 0.440 |
Why?
|
Infant, Newborn | 29 | 2024 | 26198 | 0.440 |
Why?
|
Humans | 131 | 2024 | 761504 | 0.410 |
Why?
|
Male | 89 | 2024 | 360804 | 0.400 |
Why?
|
Climate | 1 | 2012 | 147 | 0.390 |
Why?
|
Cross Infection | 1 | 2021 | 1422 | 0.380 |
Why?
|
Female | 90 | 2024 | 392644 | 0.380 |
Why?
|
Altitude | 1 | 2012 | 163 | 0.380 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2012 | 411 | 0.370 |
Why?
|
Child | 31 | 2024 | 80153 | 0.370 |
Why?
|
Respiratory System | 3 | 2022 | 563 | 0.350 |
Why?
|
Haemophilus influenzae | 3 | 2022 | 178 | 0.350 |
Why?
|
Patient Discharge | 4 | 2015 | 3443 | 0.330 |
Why?
|
Continuous Positive Airway Pressure | 3 | 2017 | 575 | 0.330 |
Why?
|
Viral Load | 4 | 2021 | 3332 | 0.310 |
Why?
|
Cohort Studies | 27 | 2024 | 41487 | 0.300 |
Why?
|
Metapneumovirus | 1 | 2008 | 28 | 0.300 |
Why?
|
Medical Staff, Hospital | 1 | 2012 | 601 | 0.300 |
Why?
|
Sequence Analysis, DNA | 2 | 2018 | 4740 | 0.290 |
Why?
|
Cathelicidins | 3 | 2017 | 80 | 0.280 |
Why?
|
Multicenter Studies as Topic | 3 | 2019 | 1702 | 0.280 |
Why?
|
Office Visits | 2 | 2010 | 595 | 0.270 |
Why?
|
Eczema | 2 | 2021 | 246 | 0.270 |
Why?
|
Feces | 3 | 2017 | 1497 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3204 | 0.250 |
Why?
|
Ethics Committees, Research | 1 | 2007 | 196 | 0.250 |
Why?
|
Spermatic Cord Torsion | 1 | 2005 | 72 | 0.250 |
Why?
|
Molecular Typing | 3 | 2021 | 116 | 0.250 |
Why?
|
Intensive Care Units | 7 | 2020 | 3745 | 0.240 |
Why?
|
United States | 35 | 2024 | 72334 | 0.240 |
Why?
|
Urinary Tract Infections | 2 | 2021 | 802 | 0.240 |
Why?
|
Intubation, Intratracheal | 1 | 2012 | 1329 | 0.230 |
Why?
|
Influenza A virus | 1 | 2008 | 458 | 0.230 |
Why?
|
Risk Factors | 23 | 2022 | 74206 | 0.220 |
Why?
|
Oseltamivir | 1 | 2024 | 75 | 0.220 |
Why?
|
Pandemics | 2 | 2020 | 8654 | 0.220 |
Why?
|
Orchiectomy | 1 | 2005 | 463 | 0.220 |
Why?
|
Emergency Medicine | 3 | 2012 | 1198 | 0.220 |
Why?
|
Metabolic Networks and Pathways | 2 | 2018 | 789 | 0.210 |
Why?
|
Antiviral Agents | 4 | 2024 | 3060 | 0.210 |
Why?
|
Albuterol | 2 | 2018 | 213 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3084 | 0.200 |
Why?
|
Respiratory Function Tests | 2 | 2024 | 1682 | 0.200 |
Why?
|
Immunoglobulin E | 4 | 2023 | 1502 | 0.200 |
Why?
|
Respiration, Artificial | 5 | 2024 | 2628 | 0.200 |
Why?
|
Recurrence | 6 | 2021 | 8465 | 0.200 |
Why?
|
Incidence | 9 | 2021 | 21353 | 0.200 |
Why?
|
Hospitals, Psychiatric | 1 | 2003 | 321 | 0.190 |
Why?
|
Child Health Services | 1 | 2007 | 646 | 0.190 |
Why?
|
Clinical Protocols | 1 | 2007 | 1440 | 0.180 |
Why?
|
Spirometry | 1 | 2024 | 929 | 0.180 |
Why?
|
Chemokine CCL5 | 2 | 2018 | 214 | 0.180 |
Why?
|
Blood Sedimentation | 1 | 2021 | 235 | 0.180 |
Why?
|
Multivariate Analysis | 10 | 2018 | 12059 | 0.170 |
Why?
|
Optic Nerve Diseases | 1 | 2003 | 342 | 0.170 |
Why?
|
Health Care Surveys | 5 | 2024 | 2426 | 0.170 |
Why?
|
Streptococcus pneumoniae | 3 | 2022 | 730 | 0.170 |
Why?
|
Sphingolipids | 2 | 2020 | 174 | 0.170 |
Why?
|
Endemic Diseases | 1 | 2020 | 190 | 0.160 |
Why?
|
Coxsackievirus Infections | 1 | 2019 | 42 | 0.160 |
Why?
|
Enterovirus | 1 | 2019 | 67 | 0.160 |
Why?
|
Cellulitis | 1 | 2020 | 209 | 0.160 |
Why?
|
Ambulatory Care | 3 | 2015 | 2775 | 0.160 |
Why?
|
Hospitals, Pediatric | 4 | 2020 | 1860 | 0.150 |
Why?
|
Seasons | 4 | 2019 | 1520 | 0.150 |
Why?
|
Metabolomics | 4 | 2024 | 1659 | 0.150 |
Why?
|
Nose | 1 | 2021 | 521 | 0.150 |
Why?
|
Time Factors | 4 | 2020 | 39967 | 0.150 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2021 | 437 | 0.150 |
Why?
|
Lyme Disease | 1 | 2003 | 631 | 0.140 |
Why?
|
Environmental Exposure | 1 | 2012 | 4486 | 0.140 |
Why?
|
Respiratory Hypersensitivity | 1 | 2019 | 273 | 0.140 |
Why?
|
Logistic Models | 8 | 2015 | 13255 | 0.140 |
Why?
|
Virus Diseases | 2 | 2015 | 718 | 0.140 |
Why?
|
Guideline Adherence | 1 | 2007 | 2220 | 0.140 |
Why?
|
Finland | 4 | 2021 | 607 | 0.140 |
Why?
|
DNA, Ribosomal | 1 | 2018 | 300 | 0.140 |
Why?
|
Age Distribution | 3 | 2008 | 2880 | 0.130 |
Why?
|
Practice Guidelines as Topic | 2 | 2018 | 7390 | 0.130 |
Why?
|
Headache | 1 | 2003 | 1256 | 0.130 |
Why?
|
Adolescent | 12 | 2024 | 88319 | 0.130 |
Why?
|
Bordetella pertussis | 1 | 2015 | 45 | 0.130 |
Why?
|
MicroRNAs | 2 | 2024 | 3816 | 0.120 |
Why?
|
Disease | 1 | 2020 | 672 | 0.120 |
Why?
|
Phenobarbital | 1 | 1996 | 191 | 0.120 |
Why?
|
Polymerase Chain Reaction | 3 | 2015 | 6075 | 0.120 |
Why?
|
Pediatrics | 2 | 2007 | 3589 | 0.120 |
Why?
|
Treatment Outcome | 11 | 2020 | 64680 | 0.120 |
Why?
|
Statistics, Nonparametric | 1 | 2020 | 2850 | 0.120 |
Why?
|
Liver Neoplasms, Experimental | 1 | 1996 | 189 | 0.120 |
Why?
|
Intensive Care Units, Pediatric | 2 | 2019 | 1017 | 0.120 |
Why?
|
Whooping Cough | 1 | 2015 | 86 | 0.120 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 1996 | 302 | 0.120 |
Why?
|
Forced Expiratory Volume | 3 | 2024 | 1814 | 0.120 |
Why?
|
Longitudinal Studies | 3 | 2020 | 14605 | 0.120 |
Why?
|
Nonprescription Drugs | 1 | 2015 | 118 | 0.110 |
Why?
|
Geography | 2 | 2007 | 656 | 0.110 |
Why?
|
Blood Proteins | 1 | 2019 | 1173 | 0.110 |
Why?
|
Saline Solution, Hypertonic | 1 | 2014 | 114 | 0.110 |
Why?
|
Adrenal Cortex Hormones | 3 | 2014 | 1880 | 0.110 |
Why?
|
Carcinogens | 1 | 1996 | 452 | 0.110 |
Why?
|
Gastroesophageal Reflux | 1 | 2020 | 819 | 0.110 |
Why?
|
Snow | 1 | 2012 | 15 | 0.110 |
Why?
|
DNA, Bacterial | 1 | 2018 | 1479 | 0.100 |
Why?
|
Patient Admission | 3 | 2010 | 1367 | 0.100 |
Why?
|
Wind | 1 | 2012 | 42 | 0.100 |
Why?
|
Rain | 1 | 2012 | 60 | 0.100 |
Why?
|
Hyponatremia | 1 | 2015 | 279 | 0.100 |
Why?
|
Siblings | 1 | 2016 | 825 | 0.100 |
Why?
|
Gestational Age | 1 | 2021 | 3577 | 0.100 |
Why?
|
Vaccination | 1 | 2024 | 3384 | 0.100 |
Why?
|
Confidence Intervals | 3 | 2010 | 2927 | 0.100 |
Why?
|
Social Behavior | 1 | 2018 | 1135 | 0.100 |
Why?
|
Infant, Premature | 1 | 2021 | 2107 | 0.100 |
Why?
|
Proportional Hazards Models | 3 | 2021 | 12463 | 0.100 |
Why?
|
Antibodies, Monoclonal | 2 | 2015 | 9177 | 0.100 |
Why?
|
Cytokines | 3 | 2019 | 7396 | 0.100 |
Why?
|
Humidity | 1 | 2012 | 205 | 0.100 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 2015 | 2518 | 0.100 |
Why?
|
Sex Distribution | 2 | 2008 | 2281 | 0.090 |
Why?
|
Hospital Charges | 1 | 2013 | 350 | 0.090 |
Why?
|
Food Hypersensitivity | 1 | 2019 | 729 | 0.090 |
Why?
|
Acute Disease | 2 | 2019 | 7237 | 0.090 |
Why?
|
Cough | 1 | 2015 | 594 | 0.090 |
Why?
|
Research Design | 1 | 2007 | 6180 | 0.090 |
Why?
|
Follow-Up Studies | 6 | 2020 | 39106 | 0.090 |
Why?
|
Prevalence | 4 | 2020 | 15732 | 0.090 |
Why?
|
Risk Assessment | 4 | 2020 | 23995 | 0.090 |
Why?
|
Vital Capacity | 2 | 2024 | 971 | 0.090 |
Why?
|
Positive-Pressure Respiration | 3 | 2020 | 639 | 0.090 |
Why?
|
Epinephrine | 1 | 2014 | 792 | 0.090 |
Why?
|
Retrospective Studies | 8 | 2024 | 80636 | 0.090 |
Why?
|
Antibiotic Prophylaxis | 1 | 2015 | 636 | 0.090 |
Why?
|
Tobacco Smoke Pollution | 1 | 2015 | 819 | 0.080 |
Why?
|
Cross-Sectional Studies | 8 | 2019 | 26125 | 0.080 |
Why?
|
Statistics as Topic | 2 | 2014 | 2358 | 0.080 |
Why?
|
Anti-Bacterial Agents | 4 | 2014 | 7407 | 0.080 |
Why?
|
Bacterial Infections | 1 | 2017 | 1390 | 0.080 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3826 | 0.080 |
Why?
|
NF-kappa B | 1 | 2018 | 2490 | 0.080 |
Why?
|
Smoking | 3 | 2015 | 9053 | 0.080 |
Why?
|
Pregnancy Complications | 2 | 2015 | 2947 | 0.080 |
Why?
|
Prevotella | 2 | 2020 | 80 | 0.080 |
Why?
|
Drug Utilization | 2 | 2012 | 1188 | 0.080 |
Why?
|
Models, Statistical | 2 | 2020 | 5079 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2020 | 3575 | 0.080 |
Why?
|
Tennessee | 1 | 2008 | 120 | 0.080 |
Why?
|
Communicable Diseases | 1 | 2016 | 875 | 0.070 |
Why?
|
Massachusetts | 1 | 2020 | 8830 | 0.070 |
Why?
|
Bacteria | 1 | 2018 | 2199 | 0.070 |
Why?
|
Health Surveys | 2 | 2009 | 4061 | 0.070 |
Why?
|
Proteome | 3 | 2022 | 1862 | 0.070 |
Why?
|
Disease Management | 3 | 2014 | 2508 | 0.070 |
Why?
|
Parents | 1 | 2020 | 3563 | 0.070 |
Why?
|
Health Insurance Portability and Accountability Act | 1 | 2007 | 105 | 0.070 |
Why?
|
Causality | 1 | 2012 | 1242 | 0.070 |
Why?
|
Probability | 2 | 2010 | 2477 | 0.070 |
Why?
|
RNA, Viral | 1 | 2014 | 2846 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3639 | 0.070 |
Why?
|
Drug Utilization Review | 1 | 2007 | 248 | 0.070 |
Why?
|
Appointments and Schedules | 1 | 2010 | 443 | 0.070 |
Why?
|
Temperature | 1 | 2012 | 2226 | 0.060 |
Why?
|
Insurance, Health | 2 | 2010 | 2498 | 0.060 |
Why?
|
Workplace | 1 | 2012 | 863 | 0.060 |
Why?
|
Young Adult | 6 | 2018 | 59243 | 0.060 |
Why?
|
Parathyroid Hormone | 1 | 2012 | 1803 | 0.060 |
Why?
|
Age Factors | 6 | 2020 | 18395 | 0.060 |
Why?
|
Interviews as Topic | 2 | 2009 | 2696 | 0.060 |
Why?
|
Fatty Acids | 2 | 2023 | 1808 | 0.060 |
Why?
|
Glucocorticoids | 1 | 2014 | 2161 | 0.060 |
Why?
|
Hospitals, County | 1 | 2003 | 17 | 0.060 |
Why?
|
Neuraminidase | 1 | 2024 | 196 | 0.060 |
Why?
|
Adrenergic beta-Agonists | 1 | 2005 | 345 | 0.050 |
Why?
|
Mental Disorders | 1 | 2003 | 6845 | 0.050 |
Why?
|
Disease Susceptibility | 2 | 2020 | 1787 | 0.050 |
Why?
|
Leukocytosis | 1 | 2003 | 251 | 0.050 |
Why?
|
Intracranial Pressure | 1 | 2003 | 324 | 0.050 |
Why?
|
Premature Birth | 1 | 2013 | 1782 | 0.050 |
Why?
|
Lipid Metabolism | 2 | 2020 | 1902 | 0.050 |
Why?
|
Prognosis | 3 | 2015 | 29625 | 0.050 |
Why?
|
Toll-Like Receptors | 1 | 2024 | 589 | 0.050 |
Why?
|
Gene Expression Profiling | 3 | 2024 | 9420 | 0.050 |
Why?
|
Predictive Value of Tests | 3 | 2020 | 15266 | 0.040 |
Why?
|
Nausea | 1 | 2003 | 679 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12974 | 0.040 |
Why?
|
Pneumonia | 1 | 2012 | 2143 | 0.040 |
Why?
|
Vomiting | 1 | 2003 | 651 | 0.040 |
Why?
|
Pregnancy | 4 | 2020 | 29874 | 0.040 |
Why?
|
Cluster Analysis | 2 | 2017 | 2707 | 0.040 |
Why?
|
Quality Indicators, Health Care | 1 | 2009 | 1792 | 0.040 |
Why?
|
Radiography | 2 | 2014 | 6965 | 0.040 |
Why?
|
Odds Ratio | 3 | 2016 | 9646 | 0.040 |
Why?
|
Anorexia Nervosa | 1 | 2008 | 1361 | 0.040 |
Why?
|
Insurance Coverage | 1 | 2010 | 1940 | 0.040 |
Why?
|
Boston | 1 | 2012 | 9326 | 0.040 |
Why?
|
Carnitine | 1 | 2020 | 252 | 0.040 |
Why?
|
Calcium | 1 | 2012 | 5722 | 0.040 |
Why?
|
Host-Pathogen Interactions | 2 | 2019 | 1459 | 0.040 |
Why?
|
Adult | 7 | 2017 | 221177 | 0.040 |
Why?
|
Decision Trees | 1 | 2020 | 504 | 0.040 |
Why?
|
Health Care Costs | 2 | 2013 | 3242 | 0.040 |
Why?
|
Corynebacterium | 1 | 2017 | 48 | 0.040 |
Why?
|
Interferon-alpha | 1 | 2022 | 921 | 0.040 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2020 | 439 | 0.040 |
Why?
|
Poisson Distribution | 1 | 2018 | 504 | 0.040 |
Why?
|
Reference Values | 1 | 2024 | 4920 | 0.030 |
Why?
|
Immunity, Innate | 2 | 2024 | 3065 | 0.030 |
Why?
|
Diethylnitrosamine | 1 | 1996 | 45 | 0.030 |
Why?
|
Regression Analysis | 2 | 2020 | 6343 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2024 | 12795 | 0.030 |
Why?
|
Expectorants | 1 | 2015 | 22 | 0.030 |
Why?
|
Mycoplasma pneumoniae | 1 | 2015 | 43 | 0.030 |
Why?
|
Antitussive Agents | 1 | 2015 | 18 | 0.030 |
Why?
|
Nasal Decongestants | 1 | 2015 | 29 | 0.030 |
Why?
|
Safety-Based Drug Withdrawals | 1 | 2015 | 36 | 0.030 |
Why?
|
Population Surveillance | 1 | 2005 | 2598 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2017 | 22176 | 0.030 |
Why?
|
Intubation | 1 | 2015 | 139 | 0.030 |
Why?
|
Rats, Inbred F344 | 1 | 1996 | 826 | 0.030 |
Why?
|
Vitamins | 1 | 2023 | 1635 | 0.030 |
Why?
|
Lung | 2 | 2023 | 10000 | 0.030 |
Why?
|
High-Frequency Ventilation | 1 | 2015 | 88 | 0.030 |
Why?
|
Multilevel Analysis | 1 | 2014 | 150 | 0.030 |
Why?
|
Fever | 1 | 2021 | 1618 | 0.030 |
Why?
|
Blood Cell Count | 1 | 2014 | 397 | 0.030 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2020 | 1133 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2024 | 3712 | 0.030 |
Why?
|
Lipids | 1 | 2023 | 3341 | 0.030 |
Why?
|
Disease Progression | 2 | 2019 | 13506 | 0.020 |
Why?
|
Nutrition Surveys | 2 | 2010 | 1733 | 0.020 |
Why?
|
Utilization Review | 1 | 2013 | 382 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 2003 | 1923 | 0.020 |
Why?
|
Mental Health Services | 1 | 2003 | 1730 | 0.020 |
Why?
|
Pre-Eclampsia | 1 | 2020 | 1231 | 0.020 |
Why?
|
Catheterization, Peripheral | 1 | 2014 | 343 | 0.020 |
Why?
|
Specimen Handling | 1 | 2015 | 702 | 0.020 |
Why?
|
Hospitals, Community | 1 | 2013 | 365 | 0.020 |
Why?
|
Hospital Costs | 1 | 2016 | 947 | 0.020 |
Why?
|
Infant, Low Birth Weight | 1 | 2015 | 870 | 0.020 |
Why?
|
Base Sequence | 1 | 2020 | 12441 | 0.020 |
Why?
|
Chronic Disease | 1 | 2003 | 9318 | 0.020 |
Why?
|
Socioeconomic Factors | 2 | 2014 | 7827 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3849 | 0.020 |
Why?
|
Gene Expression | 1 | 2021 | 7581 | 0.020 |
Why?
|
Signal Transduction | 2 | 2024 | 23445 | 0.020 |
Why?
|
Community-Acquired Infections | 1 | 2012 | 469 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2014 | 1302 | 0.020 |
Why?
|
Patient Transfer | 1 | 2015 | 794 | 0.020 |
Why?
|
Administration, Inhalation | 1 | 2010 | 1157 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9610 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2015 | 1664 | 0.020 |
Why?
|
Software | 1 | 2020 | 4434 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8631 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2022 | 3358 | 0.020 |
Why?
|
Phenotype | 1 | 2023 | 16591 | 0.020 |
Why?
|
Medically Uninsured | 1 | 2010 | 836 | 0.020 |
Why?
|
North America | 1 | 2008 | 1276 | 0.010 |
Why?
|
Mothers | 1 | 2015 | 2198 | 0.010 |
Why?
|
Emergencies | 1 | 2010 | 1217 | 0.010 |
Why?
|
Survival Analysis | 1 | 2016 | 10090 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2008 | 3416 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2006 | 1668 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14666 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 11903 | 0.010 |
Why?
|
Rats | 1 | 1996 | 23742 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17904 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2691 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20098 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2010 | 3415 | 0.010 |
Why?
|
Comorbidity | 1 | 2010 | 10508 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2009 | 3080 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2009 | 3204 | 0.010 |
Why?
|
Aged | 2 | 2012 | 169289 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2012 | 58976 | 0.000 |
Why?
|
Middle Aged | 2 | 2012 | 220895 | 0.000 |
Why?
|
Animals | 1 | 1996 | 168459 | 0.000 |
Why?
|